Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 91

Related Citations for PubMed (Select 20664291)

1.

Progressive multifocal leukoencephalopathy deaths in the USA, 1979-2005.

Christensen KL, Holman RC, Hammett TA, Belay ED, Schonberger LB.

Neuroepidemiology. 2010;35(3):178-84. doi: 10.1159/000311014. Epub 2010 Jul 24.

PMID:
20664291
2.

Epidemiology of progressive multifocal leukoencephalopathy in the United States: analysis of national mortality and AIDS surveillance data.

Holman RC, Janssen RS, Buehler JW, Zelasky MT, Hooper WC.

Neurology. 1991 Nov;41(11):1733-6.

PMID:
1944901
3.

Characteristics and antecedents of progressive multifocal leukoencephalopathy in an insured population.

Eng PM, Turnbull BR, Cook SF, Davidson JE, Kurth T, Seeger JD.

Neurology. 2006 Sep 12;67(5):884-6.

PMID:
16966559
4.

Progressive multifocal leukoencephalopathy in the United States, 1979-1994: increased mortality associated with HIV infection.

Holman RC, Török TJ, Belay ED, Janssen RS, Schonberger LB.

Neuroepidemiology. 1998;17(6):303-9.

PMID:
9778596
5.

Clinical epidemiology and survival of progressive multifocal leukoencephalopathy in the era of highly active antiretroviral therapy: data from the Italian Registry Investigative Neuro AIDS (IRINA).

Antinori A, Cingolani A, Lorenzini P, Giancola ML, Uccella I, Bossolasco S, Grisetti S, Moretti F, Vigo B, Bongiovanni M, Del Grosso B, Arcidiacono MI, Fibbia GC, Mena M, Finazzi MG, Guaraldi G, Ammassari A, d'Arminio Monforte A, Cinque P, De Luca A; Italian Registry Investigative Neuro AIDS Study Group.

J Neurovirol. 2003;9 Suppl 1:47-53.

PMID:
12709872
6.

[Progressive multifocal leukoencephalopathy in patients with AIDS: is there a change in patients treated with highly active antiretroviral therapies?].

Montes Santiago J, Pérez Fernández E, González Vázquez L, Morano Amado L, Fernández Martín J, Asorey Carballeira A, Pérez Alvarez R.

An Med Interna. 2002 May;19(5):230-3. Spanish.

PMID:
12107996
7.

Epidemiology and prognosis of AIDS-associated progressive multifocal leukoencephalopathy in the HAART era.

Antinori A, Ammassari A, Giancola ML, Cingolani A, Grisetti S, Murri R, Alba L, Ciancio B, Soldani F, Larussa D, Ippolito G, De Luca A.

J Neurovirol. 2001 Aug;7(4):323-8.

PMID:
11517411
8.

A review of progressive multifocal leukoencephalopathy in persons with and without AIDS.

Dworkin MS.

Curr Clin Top Infect Dis. 2002;22:181-95. Review. No abstract available.

PMID:
12520654
9.

Influence of HAART on the clinical course of HIV-1-infected patients with progressive multifocal leukoencephalopathy: results of an observational multicenter study.

Falcó V, Olmo M, del Saz SV, Guelar A, Santos JR, Gutiérrez M, Colomer D, Deig E, Mateo G, Montero M, Pedrol E, Podzamczer D, Domingo P, Llibre JM.

J Acquir Immune Defic Syndr. 2008 Sep 1;49(1):26-31. doi: 10.1097/QAI.0b013e31817bec64.

PMID:
18667930
10.

Highly active antiretroviral therapy significantly improves the prognosis of patients with HIV-associated progressive multifocal leukoencephalopathy.

Albrecht H, Hoffmann C, Degen O, Stoehr A, Plettenberg A, Mertenskötter T, Eggers C, Stellbrink HJ.

AIDS. 1998 Jul 9;12(10):1149-54.

PMID:
9677163
11.

Remission of progressive multifocal leukoencephalopathy following highly active antiretroviral therapy in a patient with HIV infection.

Inui K, Miyagawa H, Sashihara J, Miyoshi H, Tanaka-Taya K, Nishigaki T, Teraoka S, Mano T, Ono J, Okada S.

Brain Dev. 1999 Sep;21(6):416-9.

PMID:
10487477
12.

Progressive multifocal leukoencephalopathy in HIV-infected patients in the era of HAART: radiological features at diagnosis and follow-up and correlation with clinical variables.

Giancola ML, Rizzi EB, Lorenzini P, Rovighi L, Baldini F, Schininà V, Larussa D, Bibbolino C, Antinori A.

AIDS Res Hum Retroviruses. 2008 Feb;24(2):155-62. doi: 10.1089/aid.2006.0252.

PMID:
18240958
13.

Incidence and outcome of progressive multifocal leukoencephalopathy over 20 years of the Swiss HIV Cohort Study.

Khanna N, Elzi L, Mueller NJ, Garzoni C, Cavassini M, Fux CA, Vernazza P, Bernasconi E, Battegay M, Hirsch HH; Swiss HIV Cohort Study.

Clin Infect Dis. 2009 May 15;48(10):1459-66. doi: 10.1086/598335.

14.

The clinical profile of end-stage AIDS in the era of highly active antiretroviral therapy.

Welch K, Morse A; Adult Spectrum of Disease Project in New Orleans.

AIDS Patient Care STDS. 2002 Feb;16(2):75-81.

PMID:
11874639
15.

Survival improvement of AIDS-related progressive multifocal leukoencephalopathy in the era of protease inhibitors. Clinical Epidemiology Group. French Hospital Database on HIV.

Tassie JM, Gasnault J, Bentata M, Deloumeaux J, Boué F, Billaud E, Costagliola D.

AIDS. 1999 Oct 1;13(14):1881-7.

PMID:
10513646
16.

Progressive multifocal leukoencephalopathy--as a presenting manifestation of AIDS.

Raina S, Kaushal SS, Gupta D, Himral P, Sawal N, Sood V, Goyal A.

J Assoc Physicians India. 2007 Nov;55:797-801.

PMID:
18290557
17.

Progressive multifocal leukoencephalopathy in patients with AIDS receiving highly active antiretroviral therapy.

Tantisiriwat W, Tebas P, Clifford DB, Powderly WG, Fichtenbaum CJ.

Clin Infect Dis. 1999 May;28(5):1152-4.

18.

Malignancy in perinatally human immunodeficiency virus-infected children in the United States.

Kest H, Brogly S, McSherry G, Dashefsky B, Oleske J, Seage GR 3rd.

Pediatr Infect Dis J. 2005 Mar;24(3):237-42.

PMID:
15750460
19.
20.

The relative contributions of HAART and alpha-interferon for therapy of progressive multifocal leukoencephalopathy in AIDS.

Geschwind MD, Skolasky RI, Royal WS, McArthur JC.

J Neurovirol. 2001 Aug;7(4):353-7.

PMID:
11517416
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk